THE IMPACT AND COST-EFFECTIVENESS OF A FOUR-MONTH REGIMEN FOR FIRST-LINE TREATMENT OF ACTIVE TUBERCULOSIS IN SOUTH AFRICA.

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

BACKGROUND:A 4-month first-line treatment regimen for tuberculosis disease (TB) is expected to have a direct impact on patient outcomes and societal costs, as well as an indirect impact on Mycobacterium tuberculosis transmission.We aimed to estimate this combined impact in a high TB-burden country: South Africa.METHOD:An individual based M.tb trans

read more